The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United .
To accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs Domain Therapeutics, a biopharmaceutical company specializing in the research and development of
PARIS, May 4, 2022 /PRNewswire/ Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and
/PRNewswire/ Coave Therapeutics ( Coave ), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS.